AFT Pharmaceuticals - 14% revenue growth despite COVID-19 headwinds
AFT Pharmaceuticals recently reported its results for H122. Operating revenue grew strongly by 14% year-on-year to NZ$55.5m, despite the impact of...
688 Views
Company Coverage: Temporary Analyst Change
Company Coverage Temporary Analyst Change We temporarily transfer coverage of the following companies to Matt Montgomerie due to...
277 Views
AFT Pharmaceuticals: FY21 Result — Pain Relieving
AFT PharmaceuticalsFY21 Result — Pain Relieving RESEARCH INSIGHTS AFT Pharmaceuticals (AFT) reported an FY21 result at the upper-end of its...
620 Views
AFT Pharmaceuticals - Growth in the face of a challenging environment
AFT Pharmaceuticals recently reported its results for FY21. Operating revenue grew strongly by 7% year-on-year to NZ$113.1m, driven mainly by 11%...
537 Views
AFT Pharmaceuticals: On Script With a New Deal
AFT PharmaceuticalsOn Script With a New Deal RESEARCH INSIGHTS AFT has ticked off another milestone with the signing of an agreement for...
375 Views